N. VISHWANATHAN,AKSHAYA VISWANATHAN,S. VIMAL
DOI: https://doi.org/Artificial Intelligence (AI) and nanotechnology are emerging as transformative tools in the diagnosis, prognosis, and treatment of oral cancer. AI enhances early detection and clinical decision-making through advanced imaging, histopathological analysis, and survival prediction models, while nanotechnology enables targeted drug delivery, biomarker identification, and precision theranostics. Together, these innovations address the limitations of conventional approaches by improving sensitivity, specificity, and therapeutic efficacy, while reducing adverse effects. Their integration represents a paradigm shift toward personalized and patient-centered oral oncology. Continued research and clinical translation will further establish their role in improving outcomes and quality of life for oral cancer patients.
